Corticosteroid therapy for chronic obstructive pulmonary disease. Is it worth the risks?

Area of Science:

• Pulmonology
• Pharmacology

Background:

• Chronic obstructive pulmonary disease (COPD) management often involves addressing persistent symptoms.
• Long-term corticosteroid therapy is a potential treatment but carries risks.

Purpose of the Study:

• To evaluate the efficacy of long-term corticosteroid therapy in patients with COPD.
• To identify criteria for initiating and continuing corticosteroid treatment in COPD.

Main Methods:

• Assessing patient response to a corticosteroid trial.
• Monitoring pulmonary function and symptom changes.

Main Results:

• Most COPD patients show no significant benefit from long-term corticosteroids.
• A small subset of patients exhibits a dramatic positive response.

Conclusions:

• A corticosteroid trial is warranted for symptomatic COPD patients unresponsive to standard treatments.
• Continued corticosteroid therapy should be based on objective improvements in pulmonary function.
• Discontinuation is advised for patients without a measurable response to avoid unnecessary risks.